NIAID researchers and NIAID-supported scientists at external institutions are studying many aspects of the Ebola and Marburg viruses and how they cause disease.
This includes seeking better ways to diagnose and treat Ebola virus disease and Marburg fevers and using applied research to develop and test vaccines and treatments.
To learn about risk factors for Ebola and Marburg, as well as learn current prevention and treatment strategies visit the Medline Plus Ebola site or the visit the Centers for Disease Control and Prevention Marburgh hemorrhagic fever site.
In response, the IGC’s Economics of Ebola initiative aims to support the Governments of Sierra Leone and Liberia and their development partners by producing and disseminating credible demand-driven research, data, and analysis to ensure that policy responses are evidence based and that corrective actions are effective and well targeted.
The vast central African country has dealt with more outbreaks of this often-fatal hemorrhagic disease than any other nation.
Yet exactly why the DRC is hit so often remains an unanswered question.
An additional 33 cases are also suspected, pending laboratory confirmation.
The affected area of the country, located along its borders with Rwanda and Uganda, is also the site of frequent cross-border movement and a prolonged humanitarian crisis.
Under the current special call for proposals, the IGC is funding several research projects across Sierra Leone and Liberia on the economic impacts of the crisis and also welcomes research requests from policymakers and development partners on emerging policy questions.
This page collates the results of research on the economic impacts of Ebola led by the IGC and by development partners in order to make their policy implications more accessible.